companydata.dkcompanydata.dk

GSK 2023 ApS: Financial statements 2018

CVR: 43456415

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -266,976 and a net result of DKK -1,831,057 compared with DKK 5,057,912 the year before. Equity in the 2018 report amounted to DKK 64,646,140. The solvency ratio was 98.2%.

Gross Profit
DKK -266,976
Profit/Loss
DKK -1,831,057
Equity
DKK 64,646,140
Total Assets
DKK 65,802,994
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--267 t.-1.8 mio.64.6 mio.0
2017--357 t.5.1 mio.66.7 mio.0
2016-2.5 mio.10.5 mio.61.8 mio.0
2015-2.8 mio.5.3 mio.52.3 mio.-
2014-2.9 mio.5.7 mio.47.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

GSK 2023 ApS: The 2017 annual report is outMay 28, 2018

GSK 2023 ApS has published its annual report for 2017. Gross profit came to DKK -356,738, and the net result was DKK 5,057,912.

About GSK 2023 ApS

GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.

Source: annual report 2025, Danish Business Authority